Article
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
16 Oct 2016
Abstract excerpt
PURPOSE: Only 3% to 28% of patients referred to the urology clinic for hematuria are diagnosed with bladder cancer. Cystoscopy leads to high diagnostic costs and a high patient burden. Therefore, to improve the selection of patients for cystoscopy and reduce costs and over testing we aimed to validate a recently developed diagnostic urine assay. MATERIALS AND METHODS: Included in study were 200 patients from a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
